Largest biotech companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 20 biotech companies in the United States ranked by earnings, at PLN 34.4B, ahead of Amgen (PLN 31.2B) and Biogen (PLN 5.2B). Figures as of 20 Nov 2026, 05:42 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Gilead SciencesPLN 34.4B
- Median
- -PLN 277.3M
- Combined market value
- PLN 2.97T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | PLN 34.4B | PLN 835.2B | PLN 673.36 | 1.45% down | 35% up | ||
| 2 | AmgenAMGN · Health Care | PLN 31.2B | PLN 959.8B | PLN 1,774.35 | 1.14% down | 32% up | ||
| 3 | BiogenBIIB · Health Care | PLN 5.2B | PLN 147.7B | PLN 999.26 | 1.70% down | 49% up | ||
| 4 | ExelixisEXEL · Health Care | PLN 3.2B | PLN 65B | PLN 266.18 | 3.60% down | 63% up | ||
| 5 | Neurocrine BiosciencesNBIX · Health Care | PLN 1.9B | PLN 64.1B | PLN 633.16 | 3.85% down | 17% up | ||
| 6 | Halozyme TherapeuticsHALO · Health Care | PLN 1.3B | PLN 42.9B | PLN 376.20 | 2.88% down | 39% up | ||
| 7 | Krystal BiotechKRYS · Health Care | PLN 828.2M | PLN 37.8B | PLN 1,277.00 | 0.15% up | 54% up | ||
| 8 | Bio-TechneTECH · Health Care | PLN 735.3M | PLN 46.2B | PLN 293.96 | 0.07% down | 24% up | ||
| 9 | RepligenRGEN · Health Care | PLN 197.7M | PLN 44B | PLN 688.56 | 1.38% down | 12% up | ||
| 10 | Adaptive BiotechnologiesADPT · Health Care | -PLN 240.6M | PLN 18.4B | PLN 113.42 | 1.44% down | 74% up | ||
| 11 | Twist BioscienceTWST · Health Care | -PLN 314.1M | PLN 30.8B | PLN 451.33 | 4.07% down | 346% up | ||
| 12 | CG OncologyCGON · Health Care | -PLN 651M | PLN 29.6B | PLN 331.16 | 2.38% up | 97% up | ||
| 13 | Kodiak SciencesKOD · Health Care | -PLN 929.9M | PLN 25.9B | PLN 395.85 | 0.09% up | 399% up | ||
| 14 | Kymera TherapeuticsKYMR · Health Care | -PLN 1.3B | PLN 41.2B | PLN 482.75 | 1.44% down | 87% up | ||
| 15 | ImmunityBioIBRX · Health Care | -PLN 1.4B | PLN 28.3B | PLN 26.57 | 1.94% down | 232% up | ||
| 16 | Scholar Rock HoldingSRRK · Health Care | -PLN 1.5B | PLN 24.8B | PLN 203.67 | 4.94% up | 26% up | ||
| 17 | ImmunovantIMVT · Health Care | -PLN 2B | PLN 27.2B | PLN 131.49 | 1.96% down | 46% up | ||
| 18 | VaxcytePCVX · Health Care | -PLN 3.1B | PLN 37.4B | PLN 235.98 | 0.27% down | 23% up | ||
| 19 | Revolution MedicinesRVMD · Health Care | -PLN 4.6B | PLN 139.4B | PLN 644.65 | 0.24% down | 129% up | ||
| 20 | ModernaMRNA · Health Care | -PLN 11.4B | PLN 326.1B | PLN 805.98 | 1.29% up | 780% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0434 PLN).
Questions and answers
Which biotech companies in the United States rank first by earnings?
Gilead Sciences (PLN 34.4B), Amgen (PLN 31.2B) and Biogen (PLN 5.2B) are the top three of the 20 biotech companies in the United States ranked by earnings as of 20 Nov 2026, 05:42 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by earnings.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by earnings have a combined market value of PLN 2.97T as of 20 Nov 2026, 05:42 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.